DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Peeters M. et al.
Final results from a randomized phase 3 study of FOLFIRI {+/-} panitumumab for second-line treatment of metastatic colorectal cancer.
Ann Oncol 2014;
25: 107-116
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.